FibroGen Inc (FGEN) stock is lower by -55.75% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives FGEN stock a score of 33 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 6. FGEN's rank also includes a long-term technical score of 45. The fundamental score for FGEN is 47. In addition to the average rating from Wall Street analysts, FGEN stock has a mean target price of $14.50. This means analysts expect the stock to climb 61.65% over the next 12 months.
FGEN has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on FGEN!
FibroGen Inc (FGEN) stock has fallen -2.92% while the S&P 500 has gained 1.37% as of 11:43 AM on Tuesday, May 17. FGEN is lower by -$0.27 from the previous closing price of $9.24 on volume of 1,152,324 shares. Over the past year the S&P 500 is down -2.41% while FGEN is lower by -55.75%. FGEN lost -$3.04 per share in the over the last 12 months.
Click Here to get the full Stock Report for FibroGen Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter